Following the first descriptions of the dermatoscopic pattern of basal cell carcinoma (BCC) that go back to the very early years of dermatoscopy, the list of dermatoscopic criteria associated with BCC has been several times updated and renewed. Up to date, dermatoscopy has been shown to enhance BCC detection, by facilitating its discrimination from other skin tumors and inflammatory skin diseases. Furthermore, upcoming evidence suggests that the method is also useful for the management of the tumor, since it provides valuable information about the histopathologic subtype, the presence of clinically undetectable pigmentation, the expansion of the tumor beyond clinically visible margins and the response to non-ablative treatments. In the current article, we provide a summary of the traditional and latest knowledge on the value of dermatoscopy for the diagnosis and management of BCC.
Introduction
Following the first descriptions of the dermatoscopic pattern of BCC that go back to the very early years of dermatoscopy, gradually gathering evidence significantly enriched our knowledge on the topic [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Up to date, the value of dermatoscopy in improving the diagnosis of BCC has been extensively demonstrated, while the method continuously gains appreciation as a useful tool in the management of the tumor [1, 9, [13] [14] [15] [16] [17] .
Dermatoscopy for diagnosis of BCC
The list of dermatoscopic criteria associated with BCC has been several times updated and renewed. An analytic description of the BCC-related dermatoscopic criteria and their histopathologic correlation is quoted in Table 1 , while a characteristic example of each one of them is presented in Figures 1 and 2 [1, 9, 12, 18, 19] . Presence of collagenous stroma and fibrosis in the dermis trait. Studies report on a higher frequency of superficial BCC (sBCC) on the trunk and lower legs of women, whereas the majority of nodular BCC occur on the head and neck of men [20, 21] . Pigmentation is present in more than 50% of the tumors in skin of color, whereas less than 10% of BCCs in fair skinned individuals are pigmented ( Figure 4 ) [22] [23] [24] [25] [26] .
Furthermore, the concept of the signature pattern of BCC has been recently introduced, referring to the observation that multiple BCCs in an individual usually display a repetitive dermatoscopic pattern [27] .
Dermatoscopy improves the clinical diagnosis of BCC, enabling its detection even at an early stage, when the tumor is still clinically inconspicuous ( Figure 5 ). Dermatoscopy has also been assessed as a valuable method to differentiate BCC from other skin tumors and inflammatory skin diseases [1, 9, 13] . The reported diagnostic accuracy of dermatoscopy for BCC diagnosis has been reported to range from 95% to 99%, depending on BCC subtype and the set of diseases included in the control group [1, 9, 12, 13] . Indeed, various entities constitute the differential diagnosis of different BCC sub-types. For example, the classical nodular non-pigmented BCC has to be discriminated from squamous cell carcinoma (SCC), amelanotic melanoma and other non-pigmented tumors, while heavily pigmented variants have to be differentiated mainly from melanoma and nevi. Instead, the differential diagnosis of superficial BCC includes both skin tumors, like actinic keratosis or Bowen's disease (BD), and inflammatory skin diseases, such as psoriasis or dermatitis.
The diagnostic accuracy of dermatoscopy has been mainly tested in the field of pigmented BCC, with the well-known
Menzies method achieving a sensitivity of 97% and a specificity of 92% and 93% for differentiating pigmented BCC from melanoma and nevi, respectively ( Figure 6 ) [1] . According to the latter model, the diagnosis of pigmented BCC is based on the dermatoscopic absence of pigment network and the Superficial BCC has to be differentiated from other skin tumors (mainly in-situ SCC) and inflammatory skin diseases ( Figure 9 ). The clinical discrimination between sBCC and BD can be enhanced by dermatoscopy, which typically reveals shiny white/red structureless areas and superficial fine telangiectasia in the former and glomerular vessels in the latter [13] . Recently, Pan et al assessed the diagnostic accuracy of dermatoscopy for differentiating among sBCC, BD and solitary psoriatic plaques and found the following criteria to be associated with BCC: scattered vascular pattern, arborizing microvessels, telangiectatic or atypical vessels, milky-pink background and brown dots/globules. The authors reported a diagnostic probability of 99% if four of these six features were identified [13] . The dermatoscopic diagnosis of pigmented sBCC is usually straightforward even in small and clinically inconspicuous lesions ( Figure 10 ). This is because pigmented sBCC displays dermatoscopic criteria corresponding to dermo-epidermal melanin deposition (maple leaf-like areas, spoke wheel areas, concentric structures), which are highly specific for the diagnosis of BCC.
In contrast to its usefulness for discriminating BCC from keratinocyte skin cancer, dermatoscopy seems insufficient to differentiate between BCC and adnexal tumors [29] . The latter group comprises sebaceous, follicular, eccrine and apocrine neoplasms, several of which have been characterized as dermatoscopic "mimickers" of BCC [30] . Trichoblastoma, trichoepithelioma, pilomatrichoma, cylindroma and eccrine poroma are only some of the entities reported to dermatoscopically exhibit linear branching vessels and blue-gray globules, similar to those seen in BCC [29, [31] [32] [33] [34] [35] .
In this context, it has been suggested that the differential diagnosis might be facilitated by the observation that the vessels of adnexal tumors are usually less focused, or by the detection of whitish or yellowish structures that have been associated with follicular and sebaceous tumors, respectively [29] . However, the validity and usefulness of the latter dermatoscopic clues and the possible value of dermatoscopy for differentiating between BCC and adnexal tumors require further elucidation.
Dermatoscopy for management of BCC
In addition to its well-documented value for the diagnosis of BCC, dermatoscopy continuously gains an essential role in the management of the tumor. In our era, the therapeutic armamentarium of clinicians for BCC includes several surgical methods as well as non-surgical modalities [36] . The [Copyright: choice of the appropriate treatment depends on several factors including the histopathologic subtype, the presence of pigmentation or ulceration, the tumor depth, the anatomical site and the presence of residual disease or recurrence [36, 37] .
Dermatoscopy has been shown to provide valuable information for several of the aforementioned parameters.
Dermatoscopy for predicting the histopathologic subtype
The histopathologic subtype is the most crucial factor influencing the treatment choice for BCC [36, 38] . This is because the response rates of different tumor subtypes to a given treatment modality vary significantly. Superficial BCC, despite of its overall indolent physical course, has been classified in the past among high-risk subtypes, on the basis of its high recurrence rates after surgery [38] [39] [40] . This can be explained by the natural tendency of the tumor to expand peripherally beyond clinically visible margins, which often results in incomplete surgical excision and subsequent recurrence. In the recent years, sBCC has been shown to respond perfectly to non-ablative treatments such as imiquimod or photodynamic therapy, prompting experts to recommend the latter modalities as first-line therapeutic options for this subtype [41] [42] [43] [44] [45] [46] .
In contrast, nodular BCC is associated with high response rates to surgery (up to 98%), while non-surgical treatments are much less effective [36, [47] [48] [49] . Management of infiltrative and sclerodermiform BCC are more troublesome, since they are characterized by considerable recurrence rates following surgery (up to 40%) while they respond poorly to non-surgical modalities [36, 45, [47] [48] [49] . Mohs' surgery is suggested as the treatment of choice for the latter subtypes [50, 51] . Infiltrative and sclerodermiform BCC also display branching vessels under dermatoscopy. However, they are usually finer, more scattered and show fewer branches compared to the classic vessels of nodular BCC. In addition, in contrast to the global translucent pinkish color of nodular BCC, infiltrative BCC often exhibits white/red structureless areas, while the underlying fibrosis of sclerodermiform BCC results in a dermatoscopically whitish background [11, 12] .
In contrast, superficial BCC usually lacks the classic arborizing vessels, typically displaying superficial fine telangiectasia with relatively few ramifications. Multiple small erosions between BCC and SCC [54] [55] [56] . The dermatoscopic characteristics of BSC have been recently reported to mirror its peculiar histopathology, since the tumor shares dermatoscopic criteria of both BCC and SCC [57] . In detail, the most frequent dermatoscopic criteria of BSC are unfocused (peripheral)
arborizing vessels, keratin masses, white structureless areas, superficial scale, ulceration or blood crusts, blue-grey blotches and blood spots in keratin masses. Notably, nearly all BSC were reported to exhibit at least one BCC-related plus one SCC-related dermatoscopic feature [57] . respectively [58] .
Dermatoscopy for assessing the presence of pigmentation
The frequency of pigmentation in BCC varies significantly among different races, since pigmented BCC accounts for less than 10% of BCCs in Caucasians, while the majority of BCCs in Hispanics and Asians and virtually all BCCs in black individuals are pigmented [22] [23] [24] [25] [26] . Notably, histopathological studies found trace amounts of pigment in a considerable percentage of clinically non-pigmented BCCs [24] . This is explained by the fact that when only scarce foci of pigmentation are present, they might be insufficient to result in clinically evident pigmentation.
The presence of pigmentation is not routinely reported in histopathologic reports, since in the past it was not considered to influence the management and prognosis of the tumor [38, 39] . However, the induction of PDT in BCC treatment restored the importance of pigmentation, since its presence was shown to influence the tumor's response. In detail, case series studies reported a poor response of pigmented BCC to PDT, compared to non-pigmented variants (14% versus 62-100%) [43, 59] . This was incorporated in recent guidelines on the use of PDT, suggesting that the method is generally not recommended for pigmented tumors [43, 60] . The low efficacy of PDT in pigmented tumors has been attributed to melanin, which appears to act as a competitive light-absorbing pigment, decreasing response rates.
Effectively, the presence of clinically undetectable pigmentation might represent a diagnostic pitfall for clinicians, forcing them to apply an ineffective treatment on a subset of BCCs. This problem seems to be, at least partially, solved by the application of dermatoscopy, which was recently shown to reveal clinically undetectable pigmentation in approximately 30% of macroscopically non-pigmented BCCs, enhancing clinicians to better select tumors potentially sensitive to PDT and minimize treatment failures ( Figure 13 ) [61] .
Dermatoscopy for assessing excision margins
Positive surgical margins represent the most potent predictor of BCC recurrence [62, 63] . Incomplete surgical excision usually follows removal of tumors located on the face, while recurrence is also associated with BCC subtypes that are characterized by a tendency to expand beyond clinically-visible margins [36, 63] . The most reliable method to overcome the problem of positive surgical margins is Mohs' surgery, which is suggested as the optimal treatment for aggressive tumor subtypes (e.g, morpheaform BCC) and for BCCs located on the face [50, 51] . However, with the exception of highly be considered for defining surgical margins of BCC remains to be further elucidated.
Dermatoscopy for monitoring response to non-ablative treatments
As mentioned above, non-ablative modalities have become very popular among dermatologists for the treatment of superficial BCC, achieving high response rates [46, 65] . Instead, red/white structureless areas and/or superficial fine telangiectasia might represent equivocal features, since they do not always correspond to residual disease [66] . Effectively, detection of the latter criteria warrants close monitoring to recognize a possible recurrence of the BCC (Figure 15 ). Of note, in a series of BCCs treated with imiquimod, arborizing vessels, maple leaf-like areas and spoke-wheel areas were reported to decrease in size and number at an early stage after treatment initiation, while ovoid nests and multiple blue-gray globules persisted for a longer period of time [17] . Detection of blue-gray globules has also been reported to be valuable for early diagnosis of disease recurrence.
Conclusion
While in the past dermoscopy was considered a second-level tool for evaluation of clinically equivocal skin tumors, in our era it represents an irreplaceable part of clinical examination.
